THEON International secures €325m financing as €1.46bn defense backlog supports growth

THEON International Plc reported 35.4% first-half revenue growth and secured a new €325 million syndicated financing facility as the European defense technology company accelerates expansion beyond traditional night-vision equipment into drones, counter-UAS systems and AI-enabled surveillance. Revenue reached €248.7 million during the six months ended June 30, while adjusted EBIT increased 37.5% to €65.1 million and adjusted EBIT margin improved to 26.2%. Order intake climbed 38.5% to €232.5 million, while soft backlog reached approximately €1.46 billion with another €902 million of associated options. Management continues to target roughly €600 million of 2026 revenue and an adjusted EBIT margin above 26%, while recent acquisitions have expanded THEON International’s estimated addressable market to almost €8 billion.

The September 7 report largely confirms financial figures initially disclosed in July, but it adds an important financing development as THEON International prepares to complete a series of acquisitions. The company said the new €325 million syndicated facility, coordinated by Alpha Bank, strengthens liquidity and funding flexibility as management integrates new businesses and continues investing in higher-growth defense technologies.

THEON International’s €1.46 billion backlog provides substantial visibility as defense demand accelerates

THEON International’s first-half growth continued to outpace the broader defense market, with revenue increasing from €183.7 million to €248.7 million and order intake rising from €167.9 million to €232.5 million. Adjusted EBITDA increased 42.2% to €70 million, while adjusted EBIT reached €65.1 million and profitability remained above 26% despite investments in new products, acquisitions and capacity.

The company’s approximately €1.46 billion soft backlog is particularly significant relative to current revenue. Management said the backlog represented around 2.4 times forward revenue coverage based on the upper end of its previous fiscal 2026 sales guidance, while an additional €902 million of associated options could provide further order conversion over time.

Soft backlog should not be treated as equivalent to immediately recognized revenue because delivery schedules, procurement decisions and options can extend across multiple years. Even so, the scale provides unusual visibility for a company targeting approximately €600 million of annual sales and reflects sustained government demand for night-vision equipment, vehicle awareness systems and broader intelligence, surveillance and reconnaissance technology.

THEON International’s customer base also provides geographic diversification. More than 300,000 of the group’s systems are already in service with armed and special forces across 73 countries, including 26 NATO members, while the company won a procurement program during 2025 involving more than 100,000 night-vision goggles for Belgian and German armed forces valued at approximately €1 billion.

New orders during 2026 have broadened that exposure. THEON International announced approximately €70 million of additional orders in June, including business connected with Rheinmetall and Germany’s Future Soldier program, while earlier orders included Kappa Optronics vehicle-awareness systems for several hundred armored vehicles in a European Union country.

That mix illustrates why management is increasingly positioning THEON International as a broader defense-electronics company rather than simply a manufacturer of night-vision goggles. Government procurement remains central to revenue, but the company is expanding into technologies that could capture a larger share of spending per soldier, vehicle and unmanned platform.

€325 million financing gives THEON more flexibility for acquisitions as leverage moves higher

The new €325 million syndicated facility becomes more important when viewed alongside THEON International’s acquisition program. Net debt stood at approximately €237.9 million at June 30 and financial leverage was 1.7 times adjusted EBITDA, leaving the company with a relatively moderate leverage profile before completion of its largest planned transactions.

Management has agreed to acquire HGH Systèmes Infrarouges through the purchase of its holding company for an enterprise value of approximately €300 million. HGH develops electro-optical and infrared systems used in defense, surveillance and counter-drone applications and generates approximately €40 million of annual revenue with an EBITDA margin above 40%.

THEON International expects the HGH acquisition to be EBITDA-margin accretive and mid-single-digit accretive to earnings per share in 2027. The company said the acquisition was valued at a mid-to-high-teens EV-to-EBITDA multiple before synergies and around 10 times EBITDA after the full expected impact of run-rate synergies within two to three years.

The transaction represents THEON International’s largest acquisition to date and will be funded through debt rather than an equity issuance. Management previously estimated that leverage could rise to approximately three times on a pro forma basis following the acquisition before declining toward 2.5 times during 2027, making cash generation and integration execution considerably more important over the next several quarters.

THEON International has also agreed to acquire an initial 80% stake in French company MERIO, which designs gyro-stabilized gimbal and turret systems for aerial, ground, infrastructure-protection and maritime applications. MERIO is expected to generate more than €15 million of 2026 revenue and over €3.5 million of EBIT, while its products provide THEON International with direct exposure to unmanned aerial systems and AI-assisted video processing.

The combination of HGH and MERIO materially changes the company’s technology portfolio. THEON International is moving from soldier-focused optical systems toward airborne sensors, platform surveillance, drone payloads, automatic target detection and counter-UAS applications, areas benefiting from changing battlefield requirements and increased defense spending.

Drone, AI and counter-UAS acquisitions expand THEON’s addressable market toward €8 billion

Management estimates that recent acquisitions and partnerships have increased THEON International’s addressable market to almost €8 billion. The expansion reflects a deliberate strategy to enter faster-growing defense segments while retaining the high-margin night-vision operation that generated the company’s original scale.

HGH provides one of the clearest examples because its technology can automatically detect and classify threats over long distances using proprietary software incorporating artificial intelligence and augmented-intelligence capabilities. Those systems are particularly relevant to counter-UAS and air-defense applications, which have attracted significantly greater military investment as drones become central to modern warfare.

MERIO provides another route into unmanned platforms through compact stabilized imaging systems that can be installed on drones and other vehicles. THEON International has also signed a memorandum of understanding with Safran Electronics & Defense to establish a joint venture developing airborne electro-optical and infrared systems for unmanned aerial vehicles.

The company has additionally invested $3 million in United States-based artificial intelligence company Twin Prime as part of an effort to integrate specialized AI models across defense and security products. While the investment is small relative to THEON International’s overall capital program, it reinforces the direction of travel toward software-enhanced sensing rather than purely optical hardware.

That transition could increase both THEON International’s addressable market and the complexity of its business. Hardware manufacturing, AI software, airborne systems and counter-drone technology have different competitive landscapes and development requirements, meaning successful expansion will depend on integrating acquired expertise without weakening the operational discipline that has supported margins above 25%.

Capital expenditure already increased 74.7% during the first half to €11.8 million as the company invests in production capacity and new technologies. Management expects approximately €30 million of capital spending for the full year, while cash conversion remained strong at 83.2% despite falling modestly from 86.3% a year earlier.

THEON International’s growth targets now depend increasingly on acquisition integration and order conversion

THEON International continues to guide for approximately €600 million of fiscal 2026 revenue and an adjusted EBIT margin above 26%. The company also maintains a medium-term target of organic growth above 15% annually and has previously stated an ambition to reach €1 billion of revenue by 2029, supported by organic growth and bolt-on acquisitions.

Reaching those targets will require a strong second half because first-half revenue of €248.7 million represents less than half of the full-year goal. Management expects activity to be seasonally weighted toward the second half and indicated that further acceleration should occur during the final quarter as procurement programs move forward and newly acquired capabilities begin contributing.

Order conversion therefore becomes one of the most important indicators for investors. A €1.46 billion soft backlog provides significant visibility, but maintaining a book-to-bill ratio above one over time will be necessary if THEON International is to sustain double-digit growth beyond the current procurement cycle.

The balance sheet creates another execution test. THEON International currently has manageable leverage, but debt-funded acquisitions could push the ratio substantially higher, while the new €325 million financing facility gives management greater flexibility to complete transactions and fund integration. Strong cash generation could allow leverage to decline relatively quickly if acquired earnings arrive as expected, but weaker order conversion or integration delays would make the expanded debt burden more consequential.

THEON International shares traded higher during September 7 before the H1 report was published, but the results announcement itself came after the Euronext Amsterdam session had closed. The day’s share movement therefore should not be interpreted as an investor reaction to the newly announced €325 million financing facility or the final half-year report, with the first full market response expected when trading resumes.

The broader market performance has nevertheless remained strong during 2026 as European defense companies benefit from higher government procurement expectations. THEON International’s investment case now combines that favorable sector backdrop with company-specific execution around acquisitions, new technologies and production expansion.

If management can preserve adjusted EBIT margins above 26% while integrating HGH and MERIO, converting backlog into revenue and bringing leverage back down after the acquisitions, THEON International could emerge as a significantly broader defense-electronics platform. The risk is that rapid expansion into multiple adjacent technologies creates integration and financing complexity faster than operating cash flow can absorb it.

Key takeaways from THEON International’s €325 million financing, €1.46 billion backlog and defense expansion

• THEON International reported first-half revenue of €248.7 million, up 35.4% year over year as demand remained strong across night vision and ISR systems.
• Adjusted EBIT increased 37.5% to €65.1 million, while adjusted EBIT margin improved to 26.2% despite investment in acquisitions and new technologies.
• Order intake rose 38.5% to €232.5 million, while soft backlog reached approximately €1.46 billion with another €902 million of associated options.
• THEON International secured a new €325 million syndicated financing facility coordinated by Alpha Bank to strengthen liquidity and funding flexibility.
• The company continues to target approximately €600 million of 2026 revenue and an adjusted EBIT margin above 26%.
• THEON International has agreed to acquire HGH Systèmes Infrarouges for an enterprise value of approximately €300 million, its largest acquisition to date.
• HGH brings counter-UAS and AI-enabled electro-optical technology, while MERIO expands THEON International into stabilized imaging systems for drones and other platforms.
• Recent acquisitions and partnerships have expanded management’s estimate of THEON International’s addressable market to almost €8 billion.
• Net debt stood at approximately €238 million with leverage of 1.7 times at June 30, although acquisitions could temporarily lift leverage toward three times.
• Long-term value will depend on whether THEON International can preserve its high margins while integrating acquisitions, converting backlog and progressing toward its €1 billion revenue ambition.